COMBINING MATERNAL AGE AND SERUM ALPHA-FETOPROTEIN TO PREDICT THE RISK OF DOWN-SYNDROME
- 1 August 1986
- journal article
- research article
- Vol. 68 (2) , 177-180
Abstract
Twenty-eight cases of Down syndrome with maternal serum .alpha.-fetoprotein (AFP) measured at second trimester were added to 137 previously reported cases. Seventy-eight percent of affected pregnancies had levels at or below the median AFP value, compared with 50% of unaffected pregnancies. Maternal age at delivery and serum AFP levels by multiples of the median were used to construct a table to determine the risk of Down syndrome. This was compared with the risk for a 35-year-old woman (one in 365). Similar risks were estimated for a 21-year-old with AFP below 0.4 multiples of the median, a 23-year-old below 0.5, a 26-year-old below 0.6, and a 29-year-old below 0.7 multiples of the median. This study provides guidelines for counseling pregnant women who have low serum AFP levels.This publication has 5 references indexed in Scilit:
- Maternal serum α-fetoprotein screening of fetal trisomiesAmerican Journal of Obstetrics and Gynecology, 1985
- MATERNAL SERUM ALPHA-FETOPROTEIN MEASUREMENT: A SCREENING TEST FOR DOWN SYNDROMEThe Lancet, 1984
- Alpha-fetoprotein concentrations in maternal serum: relation to race and body weight.Clinical Chemistry, 1983
- CHROMOSOME-ABNORMALITIES AND SPONTANEOUS FETAL DEATH FOLLOWING AMNIOCENTESIS - FURTHER DATA AND ASSOCIATIONS WITH MATERNAL AGE1983
- THE EFFECT OF MATERNAL WEIGHT ON MATERNAL SERUM ALPHA‐FETOPROTEIN LEVELSBJOG: An International Journal of Obstetrics and Gynaecology, 1981